Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients

Tissue Antigens

Volumn 55, Issue 4, 2000, Pages 319-325

  Hajeer, Ali ^a   Dababneh, A ^a   Makki, R F ^b   Thomson, W ^a   Poulton, K ^a   Gonzalez Gay M A ^c   Garcia Porrua C ^c   Mattey, D L ^d   Ollier, W E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b BEIRUT ARAB UNIVERSITY   (Lebanon)

^c HOSPITAL XERAL CALDE   (Spain)

^d Staffordshire Rheumatology Centre   (United Kingdom)

Author keywords

HLA DRB1; RA; Spanish; TNF microsatellites

Indexed keywords

HLA DR ANTIGEN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; SPAIN;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; SEVERITY OF ILLNESS INDEX; SPAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034016506     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550405.x     Document Type: Article

References (25)

1. 1. Winchester RJ. B-lymphocyte allo-antigens, cellular expression, and disease significance with special reference to rheumatoid arthritis. Arch Intern Med 1977: 20: 159-63.
2. 2. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978: 298: 869-71.
3. 3. Ollier B, Thomson W. Population genetics of rheumatoid arthritis in Genetic Factors. In: Nepom G, ed. Rheumatic Disease Clinics of North America New York: WB Saunders, 1992: 741-69.
4. 4. Gregerson P, Silver J, Winchester R. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987: 30: 1205-13.
5. 5. Ollier B, Hajeer A. Does the HLA-DRB1 shared epitope really contribute that much to the development or severity of rheumatoid arthritis? Controversies in Rheumatology. London: Martin Dunitz, 1997: 1-12.
6. 6. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995: 16: 274-8.
7. 7. Jaraquemada A, Ollier W, Awad J, Young A, Festenstein H. HLA and rheumatoid arthritis: Susceptibility or severity? Dis Markers 1986: 4: 43-53.
8. 8. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/ 0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995: 22: 1032-6.
9. 9. Wordsworth P, Pile KD, Buckley JD et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992: 51: 585-91.
10. 10. Moreno I. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996: 23: 6-9.
11. 11. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 1996: 14: 397-440.
12. 12. Elliott MJ, Maini RN, Feldmann M et al. Repeated therapy with monoclonal antibody to tumor necrosis factor a (cA2) in patients with rheumatoid arthritis. Lancet 1994: 344: 1125-7.
13. 13. Pociot F, Briant L, Jungencel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNFα and TNFβ by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993: 23: 224-31.
14. 14. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Immunology 1997: 94: 3195-9.
15. 15. Hajeer AH, Worthington J, Silman AJ, Ollier WER. Association of tumor necrosis factor microsatellite polymorphisms with HLA-DB1*04-bearing haplotypes in rheumatoid arthritis patients. Arthritis Rheum 1996: 39: 1109-14.
16. 16. Arnett FC. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988: 31: 315-24.
17. 17. Dababneh F, Farhan A, Payton A, Hajeer AH, Thomson W, Ollier WER. A comparative study of HLA-DR4 subtyping by SSCP versus sequence based typing and inna-lipa strips [Abstract]. Eur J Immunogenet 1997: 24: 70.
18. 18. Yelamos J, Garcia-Lozano JR, Moreno I et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993: 36: 811-4.
19. 19. de Juan MD, Belmonte I, Barado J et al. Differential associations of HLA-DR antigens with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 or any of its subtypes. Tissue Antigens 1994: 43: 320-3.
20. 20. Planelles D, Puig N, Beneto A et al. HLA-DQA, -DQB and -DRB allele contribution to narcolepsy susceptibility. Eur J Immunogenet 1997: 24: 409-21.
21. 21. Bosch-Gimpera P. Prehistory of Europe. Madrid: Istmo, 1975.
22. 22. Kruta V. The Celts. Madrid: Edaf, 1981.
23. 23. Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996: 59: 676-83.
24. 24. Bali D, Gourley S, Kostyu DD et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immunity 1999: 1: 28-36.
25. 25. Jacob CO, Lee SK, Strassmann G. Mutational analysis of TNF-alpha gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmune disease. J Immunol 1996: 156: 3043-50.